Sonodynamic Effect of an Anti-Inflammatory Agent - Emodin on Macrophages

Ultrasound in Medicine and Biology

Volumn 37, Issue 9, 2011, Pages 1478-1485

  Gao, Qianping ^a,b   Wang, Fengping ^a   Guo, Shuyuan ^a   Li, Jingyi ^a   Zhu, Bidan ^a   Cheng, Jiali ^a   Jin, Yinghua ^a   Li, Bo ^a   Wang, Huan ^b   Shi, Sa ^a   Gao, Qiang ^c   Zhang, Zhiguo ^c   Cao, Wenwu ^c,d   Tian, Ye ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Emodin; Inflammation; Macrophage; Sonodynamic therapy

Indexed keywords

AFTER-TREATMENT; ANTI-INFLAMMATORY AGENTS; APOPTOTIC; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CYTOSKELETAL FILAMENTS; CYTOSKELETAL PROTEINS; CYTOSKELETONS; EMODIN; INFLAMMATION; INFLAMMATORY CELLS; NECROTIC CELLS; SONODYNAMIC THERAPY;

DISEASES; PATHOLOGY; PROTEINS; ULTRASONICS;

MACROPHAGES;

EMODIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL VIABILITY; CHROMATIN; CONTROLLED STUDY; CYTOSKELETON; DNA FRAGMENTATION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MACROPHAGE; NECROSIS; PRIORITY JOURNAL; RADIATION EXPOSURE; SONODYNAMIC THERAPY; ULTRASOUND THERAPY;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ATHEROSCLEROSIS; CELL CULTURE TECHNIQUES; EMODIN; FLUORESCENT ANTIBODY TECHNIQUE; MACROPHAGES; NECROSIS; PROTEIN KINASE INHIBITORS; ULTRASONIC THERAPY; ULTRASONICS;

EID: 79960956457     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.05.846     Document Type: Article

References (29)

1. Bialy D., Derkacz A., Wawrzynska M., Bednarkiewicz A., Ziolkowski P., Nowosad H., Strek W. In vitro photodynamic diagnosis of atherosclerotic wall changes with the use of mono-l-aspartyl chlorin e6. A preliminary report. Kardiol Pol 2003, 59:293-301.
2. Buytaert E., Callewaert G., Hendrickx N., Scorrano L., Hartmann D., Missiaen L., Vandenheede J.R., Heirman I., Grooten J., Agostinis P. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J 2006, 20:756-758.
3. Cai J., Razzak A., Hering J., Saed A., Babcock T.A., Helton S., Espat N.J. Feasibility evaluation of emodin (rhubarb extract) as an inhibitor of pancreatic cancer cell proliferation in vitro. JPEN J Parenter Enteral Nutr 2008, 32:190-196.
4. Casas A., Sanz-Rodriguez F., Di Venosa G., Rodriguez L., Mamone L., Blazquez A., Jaen P., Batlle A., Stockert J.C., Juarranz A. Disorganization of cytoskeleton in cells resistant to photodynamic treatment with decreased metastatic phenotype. Cancer Lett 2008, 270:56-65.
5. Chen G.L., Liu Z.Y., Wang J., Gao X., Wei L.W., Liu Y.L. Protective effect of emodin against lipopolysaccharides-induced corneal injury in rats. Chin Med Sci J 2009, 24:236-240.
6. Dai S., Hu S., Wu C. Apoptotic effect of sonodynamic therapy mediated by hematoporphyrin monomethyl ether on C6 glioma cells in vitro. Acta Neurochir (Wien) 2009, 151:1655-1661.
7. Davies M.J. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 2003, 305:761-770.
8. Hermus L., Lefrandt J.D., Tio R.A., Breek J.C., Zeebregts C.J. Carotid plaque formation and serum biomarkers. Atherosclerosis 2010, 213:21-29.
9. Hu Q., Noor M., Wong Y.F., Hylands P.J., Simmonds M.S., Xu Q., Jiang D., Hendry B.M., Xu Q. In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 2009, 24:3033-3041.
10. Jung S.H., Park J.Y., Yoo J.O., Shin I., Kim Y.M., Ha K.S. Identification and ultrastructural imaging of photodynamic therapy-induced microfilaments by atomic force microscopy. Ultramicroscopy 2009, 109:1428-1434.
11. Kereiakes D.J., Szyniszewski A.M., Wahr D., Herrmann H.C., Simon D.I., Rogers C., Kramer P., Shear W., Yeung A.C., Shunk K.A., Chou T.M., Popma J., Fitzgerald P., Carroll T.E., Forer D., Adelman D.C. Phase I drug and light dose-escalation trial of motexa-fin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment procedural and long-term results. Circulation 2003, 108:1310-1315.
12. Libby P., Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002, 8:1257-1262.
13. Liu Q., Hamblin M.R. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state. Int J Immunopathol Pharmacol 2005, 18:391-402.
14. Liu T., Jin H., Sun Q.R., Xu J.H., Hu H.T. Neuroprotective effects of emodin in rat cortical neurons against beta-amyloid-induced neurotoxicity. Brain Res 2010, 1347:149-160.
15. Lin S.Y., Lai W.W., Ho C.C., Yu F.S., Chen G.W., Yang J.S., Liu K.C., Lin M.L., Wu P.P., Fan M.J., Chung J.G. Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 2009, 29:327-335.
16. Moor A.C. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 2000, 57:1-13.
17. Ning Y., Bai Q., Lu H., Li X., Pandak W.M., Zhao F., Chen S., Ren S., Yin L. Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages. Atherosclerosis 2009, 204:114-120.
18. Osto E., Kouroedov A., Mocharla P., Akhmedov A., Besler C., Rohrer L., von ckardstein A., Iliceto S., Volpe M., Lüscher T.F., Cosentino F. Inhibition of protein kinase Cβ prevents foam cell formation by reducing scavenger receptor A expression in human macrophages. Circulation 2008, 118:2174-2182.
19. Panzarini E., Tenuzzo B., Dini L. Photodynamic therapy-induced apoptosis of HeLa cells. Ann N Y Acad Sci 2009, 1171:617-626.
20. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy-A review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004, 11:349-363.
21. Sakharov D.V., Bunschoten A., van Weelden H., Wirtz K.W. Photodynamic treatment and H2O2-induced oxidative stress result in different patterns of cellular protein oxidation. Eur J Biochem 2003, 270:4859-4865.
22. Tachibana K., Feril L.B., Ikeda-Dantsuji Y. Sonodynamic therapy. Ultrasonics 2008, 48:253-259.
23. Tang W., Liu Q., Zhang J., Cao B., Zhao P., Qin X. In vitro activation of mitochondria-caspase signaling pathway in sonodynamic therapy-induced apoptosis in sarcoma 180 cells. Ultrasonics 2010, 50:567-576.
24. Waksman R., McEwan P.E., Moore T.I., Pakala R., Kolodgie F.D., Hellinga D.G., Seabron R.C., Rychnovsky S.J., Vasek J., Scott R.W., Virmani R. Photo-point photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. J Am Coll Cardiol 2008, 52:1024-1032.
25. Wang P., Wang X., Liu Q., Zhao X., Cao B., Zhao P. Comparison between sonodynamic effects with protoporphyrin IX and hematoporphyrin on the cytoskeleton of Ehrlich ascites carcinoma cells. Cancer Biother Radiopharm 2010, 25:55-64.
26. Wang P., Xu C., Xia X., Xu J., Wang X., Xiang J., Leung A.W. Mitochondrial damage in nasopharyngeal carcinoma cells induced by ultrasound radiation in the presence of hypocrellin B. J Ultrasound Med 2010, 29:43-50.
27. Wang X.B., Liu Q.H., Mi N., Wang P., Tang W., Zhao X.H., Li X.J. Sonodynamically induced apoptosis by protoporphyrin IX on hepatoma-22 cells in vitro. Ultrasound Med Biol 2010, 36:667-676.
28. Zhao X., Liu Q., Tang W., Wang X., Wang P., Gong L., Wang Y. Damage effects of protoporphyrin IX-Sonodynamic therapy on the cytoskeletal F-actin of Ehrlich ascites carcinoma cells. Ultrason Sonochem 2009, 16:50-56.
29. Zhou M., Xu H., Pan L., Wen J., Guo Y., Chen K. Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice. Tohoku J Exp Med 2008, 215:61-69.